Does orthotopic liver transplantation normalize copper metabolism in patients with Wilson's disease?
Diaz, J.; Acosta, F.; Cañizares, F.; Bueno, F.S.; Tornel, P.L.; Tovar, I.; Contreras, R.F.; Marquez, M.; Martinez, P.; Parrilla, P.
Transplantation Proceedings 27(4): 2306
1995
ISSN/ISBN: 0041-1345 PMID: 7652819 Document Number: 443460
Document emailed within 1 workday
Related Documents
Kobayashi, S.; Ochiai, T.; Hori, S.; Suzuki, T.; Shimizu, T.; Gunji, Y.; Shimada, H.; Yamamoto, S.; Ogawa, A.; Kohno, Y.; Sunaga, M.; Shimazu, M.; Tanaka, K. 2001: Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor Hepato-Gastroenterology 48(41): 1259-1261Lerut, J.; Stieber, A.C.; Makowka, L.; Esquivel, C.O.; Iwatsuki, S.; Gordon, R.D.; Starzl, T.E. 1989: Long-term results of orthotopic liver transplantation during the cyclosporin era. 393 orthotopic liver transplantations accomplished in 313 consecutive patients at the Pittsburgh Transplantation Center Helvetica Chirurgica Acta 56(3): 405-420
Marecek, Z.; Heyrovský, A.; Volek, V. 1975: The effect of long term treatment with penicillamine on the copper content in the liver in patients with Wilson's disease Acta Hepato-Gastroenterologica 22(5): 292-296
Odièvre, M.; Benard, J.M.; Debray, H.; Neveu, Y.; Leleu, C.; Yvart, J.; Labrune, P.; Archambaud, F.; Bedossa, P.; Le Stradic, C. 1988: Wilson's disease with liver copper in normal concentration Archives Francaises de Pediatrie 45(8): 565-567
Suzuki, K.T. 1995: Disordered copper metabolism in LEC rats, an animal model of Wilson disease: roles of metallothionein Research Communications in Molecular Pathology and Pharmacology 89(2): 221-240
Pawlak, J. 1975: Copper metabolism disorders as an attempt at explaining analogous pathological mechanisms in Wilson's syndrome and severe cases of liver cirrhosis Wiadomosci Lekarskie 28(12): 1041-1044
Wawschinek, O.; Beyer, W. 1982: Determination of copper in liver puncture samples in the diagnosis of Wilson's disease Journal of Clinical Chemistry and Clinical Biochemistry 20(12): 929-930
Stephens, J.; Goldstein, R.; Crippin, J.; Husberg, B.; Holman, M.; Gonwa, T.A.; Klintmalm, G. 1993: Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients Transplantation Proceedings 25(1 Part 2): 1122-1123
Terajima, H.; Tanaka, K.; Okajima, K.; Inomata, Y.; Yamaoka, Y. 1995: Timing of transplantation and donor selection in living related liver transplantation for fulminant Wilson's disease Transplantation Proceedings 27(1): 1177-1178
Picache, R.S.; Kapur, B.M.; Starzl, T.E. 1970: The effect of liver disease on the need for venous decompression during the anhepatic phase of canine orthotopic liver transplantation Surgery 67(2): 319-321
Guérin, J.M.; Raux, M.; Meresse, S.; Lamotte, M. 1982: Peritoneal dialysis for eliminating copper in patients with Wilson's disease La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 58(10): 613-615
Dabrowska, E.; Jabłońska-Kaszewska, I.; Oziebłowski, A.; Porzezińska, B.; Falkiewicz, B. 2000: Liver transplantation in a patient with hemolytic syndrome in the course of fulminant Wilson's disease Przeglad Lekarski 57(6): 362-365
Lee, H.H.; Hill, G.M.; Sikha, V.K.; Brewer, G.J.; Prasad, A.S.; Owyang, C. 1990: Pancreaticobiliary secretion of zinc and copper in normal persons and patients with Wilson's disease Journal of Laboratory and Clinical Medicine 116(3): 283-288
Toulon, P.; Ledjev, I.; Ozier, Y.; Garnier, J.F.; Houssin, D. 1992: Lack of correction of acquired heparin cofactor II deficiency in patients with liver failure after successful orthotopic liver transplantation Thrombosis and Haemostasis 68(2): 230-231
Wang, X.-h.; Cheng, F.; Zhang, F.; Li, X.-c.; Qian, J.-m.; Kong, L.-b.; Zhang, H.; Li, G.-q. 2003: Living donor liver transplantation treatment of Wilson's disease complicated with neuropathy Zhonghua Yi Xue Za Zhi 83(18): 1569-1571
Lee, D.Y.; Brewer, G.J.; Wang, Y.X. 1989: Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model Journal of Laboratory and Clinical Medicine 114(6): 639-645
McQuaid, A.; Lamand, M.; Mason, J. 1992: The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy Journal of Laboratory and Clinical Medicine 119(6): 744-750
Denecke, C.; Weiss, S.; Biebl, M.; Fritz, J.; Dziodzio, T.; Aigner, F.; Sucher, R.; Brandl, A.; Bösmüller, C.; Pratschke, J.; Öllinger, R. 2016: An Arterial Conduit is Not a Risk Factor for Survival Following Orthotopic Liver Transplantation: An Analysis of 20 Years of Liver Transplantation in Innsbruck Annals of transplantation 21: 321-328
Degli Esposti, A.; Antener, I.; Ambrosioni, G.; Bonfiglioli, G. 1976: Wilson's disease. Summary of studies carried out in a family group with Wilson's disease. Significance of amino-acid balance in homo and heterozygotes for the detection of liver damage Minerva Pediatrica 28(34): 2063-2086
Ishine, N.; Tanaka, N.; Yagi, T.; Oishi, M.; Ishikawa, T.; Orita, K. 1996: Postreperfusion syndrome in swine liver transplantation: comparison between orthotopic liver transplantation and total hepatectomy with portacaval shunt using aortic graft Transplantation Proceedings 28(3): 1756-1758